540 studies found for:    glioma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Conditions: Brain Cancer;   Glioma
Intervention: Procedure: MRI and advanced MRI sequences
22 Recruiting Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
Condition: Glioma
Intervention: Drug: nilotinib
23 Recruiting Supratotal Resection for Gliomas Within Noneloquent Areas
Condition: Glioma
Interventions: Procedure: total resection;   Procedure: supratotal resection
24 Unknown  Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Condition: Glioma
Intervention: Biological: GM-K562 Vaccination
25 Recruiting Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion"
Conditions: Recurrent IDHwt Gliomas With FGFR3-TACC3 Fusion;   Recurrent IDHwt Gliomas With FGFR1-TACC1 Fusion
Intervention: Drug: AZD4547
26 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
Condition: Glioma
Intervention: Drug: 68Ga-BNOTA-PRGD2
27 Recruiting Non Invasive IDentification of Gliomas With IDH1 Mutation
Condition: Non Invasive Diagnosis of Glioma
Intervention:
28 Unknown  Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma
Condition: Recurrent Malignant Glioma
Intervention: Drug: Bevacizumab / Irinotecan
29 Recruiting A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas
Conditions: Glioblastoma;   Glioma
Intervention: Drug: Selinexor
30 Recruiting 5-ALA in Recurrent Glioma
Condition: Glioma
Intervention: Drug: 5-ala
31 Recruiting Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
Condition: OMS Grade II Glioma
Intervention: Behavioral: neurocognitive tests
32 Recruiting Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
Conditions: Glioblastoma Multiforme;   Fibrillary Astrocytoma of Brain;   Glioma of Brainstem;   Anaplastic Astrocytoma;   Pilomyxoid Astrocytoma;   Mixed Oligodendroglioma-Astrocytoma;   Brain Stem Glioma;   Diffuse Intrinsic Pontine Glioma
Intervention: Drug: SIACI of Erbitux and Bevacizumab
33 Recruiting Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy
Conditions: Brain Cancer;   Brain Stem Glioma
Intervention: Radiation: Radioactive iodine-labeled monoclonal antibody 8H9
34 Recruiting Hemostasis Alterations in Neurosurgical Patients
Conditions: Glioma;   Coagulopathy;   Acquired Platelet Function Disorder;   Thromboelastometry;   Surgery
Interventions: Procedure: Exposure to glioma resection surgery;   Procedure: Exposure to colon resection surgery
35 Recruiting CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
Conditions: EphA2 Positive Malignant Glioma;   CAR-T Cell Immunotherapy
Intervention: Biological: CAR-T cell immunotherapy
36 Not yet recruiting Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
Condition: Low Grade Glioma
Interventions: Drug: Vinblastine;   Drug: Bevacizumab
37 Recruiting PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Conditions: Pediatric Recurrent Progressive Low-grade Gliomas;   Pediatric Progressive Low-grade Gliomas
Intervention: Drug: Everolimus
38 Not yet recruiting First in Patient Study for PF-06840003 in Malignant Gliomas
Conditions: Oligodendroglioma;   Astrocytoma;   Malignant Glioma
Intervention: Drug: PF-06840003
39 Recruiting Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
Condition: Malignant Glioma
Interventions: Radiation: Hypofractionated Stereotactic Irradiation (HFSRT);   Drug: Pembrolizumab;   Drug: Bevacizumab
40 Recruiting Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
Conditions: Malignant Gliomas;   Oligodendrogliomas;   Astrocytomas
Intervention: Device: 3 Tesla scanning

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years